Ulcerative tuberculosis

Abstract

Tuberculosis (TB), one of the most devastating endemic diseases in the world, has been aggravated by the HIV-AIDS epidemic [1]. The incidence of cutaneous TB, a rare chronic manifestation (1% of all TB cases), has become more frequent not only because of the epidemic, but because of the increased use of pharmaceutical immunosuppressants. Cutaneous tuberculosis occurs in a variety of clinical forms that depend on how bacilli reach the skin and the immune status of the individual [2]. Cases at the cutaneous level are usually spread by blood and/or lymphatic pathways from a primary focus, although they may be introduced directly by trauma to the skin or mucous membranes in certain cases.